Unproven Stem Cell Treatments and Re-evaluating the Role of the U.S. FDA: Bringing the Lost and Desperate Back Home
May 23, 2015 | Kirstin R.W. Matthews, Ana S. Iltis

Table of Contents
Author(s)
Kirstin R.W. Matthews
Fellow in Science and Technology PolicyAna S. Iltis
Nonresident Fellow for Biomedical Research PolicyThis poster presentation by the International Stem Cell Policy Program focuses on unproven stem cell treatments and the marketing of experimental interventions.